Nephrotic Syndrome Disappeared after Gemcitabine Combination Therapy in a Patient with Progressive Non-small Cell Lung Cancer.
- Author:
Eun Jung LEE
1
;
Jae Jin LEE
;
Ju Young MOON
;
Jee Hong YOO
;
Cheon Woong CHOI
;
Yee Hyung KIM
;
Gou Young KIM
Author Information
1. Department of Medical Oncology & Hematology, East-West Neo Medical Center, Kyung Hee University, Seoul, Republic of Korea. lj2lj2@hanmail.net
- Publication Type:Case Report
- Keywords:
Nephrotic syndrome;
Non-small cell lung carcinoma;
Chemotherapy;
Gemcitabine
- MeSH:
Carcinoma, Non-Small-Cell Lung;
Deoxycytidine;
Humans;
Male;
Nephrotic Syndrome;
Proteinuria
- From:Korean Journal of Nephrology
2010;29(5):634-637
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Nephrotic syndrome has been reported to accompany a malignancy. Since the first case of the nephrotic syndrome associated with extra-renal malignancy was reported in 1922, only a few cases of nephrotic syndrome accompanying other malignancies have been reported. Previous reports on such cases indicated a pattern of improvement in nephropathy as malignancy improved. But the cases of resolved nephropathy with aggravated cancer have scarcely been documented. Here we report a case of a 69 year-old male with nephrotic syndrome accompanying non-small cell lung cancer, whose proteinuria was normalized after chemotherapy while his cancer was aggravated.
